Sponsored by the American Association for the Study of Liver Diseases (AASLD)

AASLD, in conjunction with the Global Liver Institute, will hold a briefing focused on establishing a national strategy to advance prevention, treatment, and diagnosis of nonalcoholic steatohepatitis (NASH), the most severe form of nonalcoholic fatty liver disease.

For more information, click here. To RSVP, click here.